| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Greenwich Lifesciences, Inc. (GLSI) has 1 insider with recent SEC Form 4 filings, including 10 buys and 0 sells. GLSI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 5.61M | $80.75M | +7.3K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 2023 | Patel Snehal61 | CEO And CFO | Buy | 2,500 | $7.97 | $19,925.00 | - | +3.9% | +63.2% | |
| Oct 25, 2023 | Patel Snehal61 | CEO And CFO | Buy | 2,500 | $7.91 | $19,775.00 | - | +9.2% | +70.9% | |
| Oct 10, 2023 | Patel Snehal61 | CEO And CFO | Buy | 1,000 | $9.07 | $9,070.00 | - | +4.3% | +39.4% | |
| Oct 4, 2023 | Patel Snehal61 | CEO And CFO | Buy | 2,000 | $8.63 | $17,260.00 | - | +27.5% | +61.3% | |
| Sep 26, 2023 | Thompson Jaye53 | VP Clinical Reg Affairs | Buy | 600 | $8.71 | $5,226.00 | +0.2% | +29.8% | +77.6% | |
| Sep 19, 2023 | Patel Snehal61 | CEO And CFO | Buy | 4,000 | $8.95 | $35,800.00 | - | +14.0% | +59.0% | |
| Sep 11, 2023 | Patel Snehal61 | CEO And CFO | Buy | 1,000 | $9.48 | $9,480.00 | - | +18.1% | +54.2% | |
| Aug 22, 2023 | Patel Snehal61 | CEO And CFO | Buy | 1,000 | $9.97 | $9,970.00 | - | +10.0% | +48.0% | |
| Aug 4, 2023 | Patel Snehal61 | CEO And CFO | Buy | 2,000 | $10.55 | $21,100.00 | - | -18.2% | +36.0% | |
| Jul 21, 2023 | Patel Snehal61 | CEO And CFO | Buy | 1,000 | $9.20 | $9,200.00 | - | -9.1% | +63.0% |